Navigation Links
Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
Date:8/5/2008

(2)

----------- --------

Assets

Cash, cash equivalents and marketable

securities $427,385 $469,650

Other current assets 39,712 11,006

-------- --------

Total current assets 467,097 480,656

Property and equipment, net 2,529 3,146

Marketable securities, non-current 43,830 -

Other assets 274 281

-------- -------

Total assets $513,730 $484,083

-------- -------

Liabilities and stockholders' equity

Current liabilities 19,599 11,441

Advance from collaboration partner 24,861 39,234

Other long term liabilities 1,218 1,171

Stockholders' equity 468,052 432,237

Total liabilities and stockholders'

equity $513,730 $484,083

-------- --------

(2) Derived from the audited financial statements included in the

Company's Annual Report on Form 10-K for the year-ended December 31,

2007.

ONYX PHARMACEUTICALS, INC.

RECONCILIATION OF GAAP TO NON-GAAP NET INCOME

(In thousands, except per share amounts)

(unaudited)

Three Months Ended Six Months Ended


'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...care employment grew by 29,000 jobs in October, a...nt growth during the U.S. recession. However, clin... health systems are coming closer to having to act...istrators. , (Vocus) Nove...growing in October despite the shedding of jobs in...
(Date:11/24/2009)...-Asia/--NODPharmaceuticalsInc.announced,theUSPaten...cationfor,itsnano-particleoraldeliveryorNODtechnol...htoincorporatepeptidesor,proteinsintobio-adhesiven...administeredasinjections.NODtechnologyisaplatformt...ssuchasinsulin,interferon,growthhormone,exenatide...
(Date:11/24/2009)...-Asia/--ShanghaiBiolaxyannouncedthe,ChineseStateFo...stigationalnewdrugapplication(IND)foritsoralinsuli...treatdiabetes.ThisIND,approvalallowsBiolaxytoiniti...disordercharacteristicofhighbloodglucoseandpoor,me...veremicro-and,macro-vasculardiseases,lossofvision,...
(Date:11/24/2009)...recently approved the Promega PowerPlex 16 HS Syst...erating DNA records for the National DNA Index Sys...RWEB) -- The FBI recently approved the Promega Po... participating in, or generating DNA records for, ...ly contains more than seven million profiles and h...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...-for-10 split ratio, SEATTLE, Aug. 25 Cell Thera...ed that its Board of Directors has,authorized a 1-...rse split,will become effective as of August 31, 2... Lieu of Annual Meeting of,Shareholders held on Ju...uthorize the Board, in its discretion, to effect a...
... Eisai Corporation of,North America and its partn...U.S. Food and Drug Administration (FDA) has approv...n hydrochloride) for the prevention of,chemotherap...es 0.5 mg for,oral administration is indicated for...wing initial and repeat courses of moderately emet...
...2 Beckman,Coulter, Inc. (NYSE: BEC ), a leading ...that simplify, automate, and innovate complex biom...k, Beckman Coulter,s senior vice,president and chi...eisel,Healthcare Conference 2008 on Thursday, Sept...www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ), ...
Other Biology Technology:Cell Therapeutics, Inc. Announces Reverse Stock Split 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 3
(Date:11/25/2009)...ria don,t have easy lives. In addition to mammalia...natural enemies called bacteriophages, viruses tha... , Still, bacteria and another class of microorg... environments such as deep-sea volcanic vents) man...e a built-in defense system that helps protect the...
(Date:11/25/2009)... a lifetime, the heart pumps some 250 million lite...his, the muscle fibers of the heart have to be ext...olfgang Rottbauer, vice chair of the Department of...hairman: Prof. Dr. H. A. Katus), has discovered a ...he smallest muscular unit, the sarcomere. In coope...
(Date:11/24/2009)... Institute (LRI) today named 12 new grant recipien...cognize innovative work across a broad spectrum of...ivity, novelty, and potential to drive scientific ...he complex disease of systemic lupus. , The 2009...rchers across the nation and include interdiscipli...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 1 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 2 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 3Cord Blood America Continues to Reduce Debt 3B Three Notes Retired 5207 1Cord Blood America Continues to Reduce Debt 3B Three Notes Retired 5207 2DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 1DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 2DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 3
...d sizes, from grand Redwood trees to the common Sn...und plants rely on a complex network of roots. Wha... mystery, but a new paper published this week in ... root can determine how further roots branch from .... The work also suggests that the root-patterning ...
..., 2008 The elevated carbon dioxide levels expecte...ikely lead to physiological impairments of jumbo (...niversity of Rhode Island scientists., The result...or of biological sciences, and Rui Rosa, a former ...e University of Lisbon, Portugal, is reported in t...
... plumes of hot rock deep within the earth are link... researchers have found. , The two superplumes, ...ave likely existed for at least 200 million years,...rth sciences at Ohio State University. , The gian...- rise from the bottom of Earth,s mantle, just abo...
Other Biology News:Ocean acidification from CO2 emissions will cause physiological impairment to jumbo squid 2Ancient magma 'superpiles' may have shaped the continents 2Ancient magma 'superpiles' may have shaped the continents 3
Goat Anti-Human Factor VIII Polyclonal Antibody, Unconjugated from Abcam
Chicken Anti-Human Thioredoxin domain containing 9 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-L-isoleucine Antibody, Unconjugated from QED Bioscience Inc.
Rabbit Anti-FOXJ2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: